Spineway (ALSPW) Q3 2026 TU earnings summary

Executive summary

• 9M 2026 revenue was €8.0 million, down 7% YoY; Q3 revenue fell 25% to €2.3 million amid subcontractor supply challenges.

• Sales momentum remained strong overall, but quarterly revenue was uneven; regional performance ranged from strong growth in Asia to declines in Latin America and the Middle East and Africa.

Financial highlights

• 9M revenue was €8.029 million versus €8.618 million in 2025, a 7% decline.

• Q3 revenue was €2.287 million versus €3.045 million in 2025, down 25% YoY.

• Q1 revenue was €2.177 million, down 23% YoY; Q2 revenue was €3.565 million, up 30% YoY.

Outlook and guidance

• Marketing authorizations for arthrodesis and intervertebral disc replacement product lines are expected soon in key Latin American countries.

• 2026 revenue is scheduled for release on January 26, 2027.